Diabetes Products Firms Push For Revisions In DMEPOS Quality Standards
This article was originally published in The Gray Sheet
Executive Summary
Leading manufacturers of blood glucose monitoring systems continue to express concern that CMS' proposed quality standards for suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) will impede diabetes patients' access to needed products
You may also be interested in...
CMS Quality Standards For Equipment Suppliers Need Reworking – AdvaMed
CMS should remove the financial management provisions from its proposed quality standards for suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS), AdvaMed says in Nov. 28 comments
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.